DRUG NAME: Daratumumab
(indirect antiglobulin test) 2. false •positive Coombs test may persist for up to six months post treatment; detection of antibodies to minor serum antigens may be masked . daratumumab binds to CD38 on red blood cells : type and screen patients prior ... Direct intravenous do NOT use ...
Tags:
Tests, Direct, Antiglobulin, Antiglobulin test
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
BC CANCER HAZARDOUS DRUG LIST
www.bccancer.bc.caBC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:
Oncology Nutrition High Protein High Energy …
www.bccancer.bc.caHigh Protein High Energy Food Choices 3 Examples of High Protein Foods • All meat (eg. beef, pork, goat, lamb) • Fish and shellfish • All poultry (eg. chicken, turkey, duck)
High, Food, Energy, Nutrition, Oncology, Protein, Oncology nutrition high protein high energy, Protein foods
Safe Handling of Hazardous Drugs - BC Cancer
www.bccancer.bc.caA.1 Potential Hazards of Handling Hazardous Drugs..... 1 A.2 Hazardous Drug List.....
“Magic” mouthwash explained - BC Cancer
www.bccancer.bc.caFAMILY PRACTICE ONCOLOGY NETWORK JOURNAL / FALL 2014 3 “Magic” mouthwash explained By Dr. Allan Hovan, Provincial Professional Practice Leader,
Symptom Management Guidelines: ORAL …
www.bccancer.bc.caSymptom Management Guidelines: ORAL MUCOSITIS . Definition Oral Mucositis (Stomatitis): An acute inflammation and/or ulceration of the …
Guidelines, Management, Symptom, Oral, Symptom management guidelines, Oral mucositis, Mucositis
Guidelines for Management of CID - BC Cancer
www.bccancer.bc.caDisclaimer Both the format and content of the guidelines will change as they are reviewed and revised on a periodic basis. Any physician using these guidelines to provide
British Columbia Cancer Agency POLICY
www.bccancer.bc.caBritish Columbia Cancer Agency ¦ POLICY Title: PREVENTION AND MANAGEMENT OF EXTRAVASATION OF CHEMOTHERAPY Number: III-20 Effective Date: Provincial Systemic Program September 1,1997
Policy, Management, Prevention, Agency, Columbia, British, Cancer, British columbia cancer agency policy, British columbia cancer agency, 166 policy
Symptom Management Guidelines: FEVER AND …
www.bccancer.bc.caSymptom Management Guidelines: FEVER AND NEUTROPENIA . Definition • Fever: A single oral temperature of ≥ 38.3° C (101° F) OR a temperature ≥ 38 ° C (100.4 ° F) which lasts more than 1h
Guidelines, Management, Fever, Symptom, Oral, Symptom management guidelines, Fever and, Fever and neutropenia, Neutropenia
Symptom Management Guidelines: XEROSTOMIA
www.bccancer.bc.caSymptom Management Guidelines: XEROSTOMIA. Definition(s) • Xerostomia: abnormal dryness in the mouth characterized by a marked decrease and/or thickening of saliva, may be
Guidelines, Management, Symptom, Symptom management guidelines, Xerostomia
Linking the BC Psychosocial Community Oncology …
www.bccancer.bc.caCarolyn Jacob - New Regional Professional Practice Leader at the Centre for the North. We welcome Carolyn Jacob, MSW, RSW to her new role at the BC
Psychosocial, Community, Linking, Oncology, Linking the bc psychosocial community oncology
Related documents
Guideline: Neonatal jaundice - Queensland Health
www.health.qld.gov.auCoombs test See Direct Antiglobulin Test. Direct Antiglobulin Test (DAT) An agglutination test that detects the presence of antibodies that are bound to red blood cells cause haemolysis. It is also known as a Coombs test.
Guidelines, Tests, Direct, Neonatal, Jaundice, Neonatal jaundice, Antiglobulin, Direct antiglobulin test
Immune Globulin Intravenous (Human) 10%
www.albertahealthservices.caFalse positive results in serological tests may occur (e.g. CMV serology, Direct Antiglobulin Test, etc.). Provide patient notification documentation where required. STORAGE & STABILITY: Store at 2-8°C until expiry (up to 36 months from date of manufacture). oMay be stored for up to 6 months at room temperature (up to 25C).
The Management of Women with Red Cell Antibodies during ...
www.rcog.org.ukdirect antiglobulin test (DAT), haemoglobin and bilirubin levels. Management How should the neonate be managed? This depends on the risk of haemolysis or anaemia conferred by the relevant red cell antibody. The neonate should have regular clinical assessment of its neurobehavioural state and be observed for the
Elution Techniques in Blood Bank
www.americanmedtech.orgPrior to performing an elution, a direct antiglobu-lin profile (DAT) should be performed on the patient's red blood cells. If the DAT is negative or positive with complement only, the likelihood of retrieving an anti-body from the red cells is not likely. Thus, performing an elution on cells with a negative DAT or sensitized